By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Gilead Sciences, Inc. 

333 Lakeside Drive

Foster City  California  94404  U.S.A.
Phone: 800-GILEAD-5 or 650-574-3000 Fax: 650-522-5800


Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need.The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

Key Statistics

Ownership: Public

Web Site: Gilead
Employees: 4,000
Symbol: GILD


Company News
How Brexit Is Affecting UK’s Drug Companies, Including GlaxoSmithKline (GSK), Gilead (GILD) and AstraZeneca PLC (AZN) 6/27/2016 10:13:46 AM
Gilead (GILD)'s Plan to Dominate the Hepatitis C Market 6/27/2016 7:55:14 AM
European Commission (EC) Grants Marketing Authorization For Gilead (GILD)’s Single Tablet Regimen Odefsey (Emtricitabine, Rilpivirine, Tenofovir Alafenamide) For The Treatment Of HIV 6/23/2016 10:45:55 AM
What Gilead (GILD) and Martin Shkreli Have in Common 6/23/2016 6:48:25 AM
Two Upstarts that Could Dislodge Gilead (GILD)'s Hold on the Hepatitis C Market 6/22/2016 6:46:38 AM
5 Biotech Stocks at Bargain Basement Prices 6/21/2016 7:42:08 AM
Gilead (GILD) Presents Preliminary Data On Bictegravir, An Investigational Integrase Strand Transfer Inhibitor For The Treatment Of HIV 6/20/2016 8:26:07 AM
Gilead (GILD) To Present At The 36th Annual William Blair Growth Stock Conference On Tuesday, June 14 6/14/2016 8:14:58 AM
Gilead (GILD) To Present At The Jefferies 2016 Healthcare Conference On Friday, June 10 6/10/2016 10:23:52 AM
Days After Judge Overturns Merck & Co. (MRK)-Gilead (GILD) Lawsuit, Merck Acquires Bay Area's Afferent Pharma for $1.2 Billion 6/10/2016 5:53:03 AM